Posters

Visual performance and patient satisfaction after implantation of AcrySof® IQ PanOptix®

Poster Details

First Author: A.Mularoni SAN MARINO

Co Author(s):    A. Imburgia   G. Mussoni                 

Abstract Details

Purpose:

To report visual performance, patient satisfaction, stability and posterior capsular opacification (PCO) incidence in 20 patients underwent bilateral cataract surgery with implantation of AcrySof IQ Trifocal PanOptix intraocular lens compared to a second group of 20 patient with AcrySof IQ Monofocal (SN60WF)

Setting:

Department of Ophthalmology - San Marino Hospital - Chief: Dr A. Mularoni

Methods:

40 eyes were evaluated after implantation of PanOptix IOL (Group 1 – 20 eyes) and Monofocal SN60WF (Group 2 – 20 eyes). We evaluated far visual acuity, intermediate visual acuity and near visual acuity at 1, 3 and 6 months postoperatively. Defocus curve (from -4.00 D to +2.00 D), mesopic (3 cd/m2) and photopic (85 cd/m2) contrast sensitivity (MOS 22 – Dueffe Tecnovision) and aberrometry (OSIRIS – CSO) were evaluated 6 months post-operatively. To evaluate patient satisfaction, a questionnaire (NEI-RQL-42TM) was compiled by the patients 6 months after surgery. PCO incidence and IOL stability were assessed by digital photos.

Results:

All eyes in both groups achieved UCVA of 0.10 logMAR or better 6 months postoperatively. 80% (16 eyes) in Group 1 achieved UIVA and UNVA of 0.1 or better. Defocus curve showed a smooth transition between far and near focus in Group 1; contrast sensitivity was normal under photopic and mesopic conditions in both Group. Patient satisfaction was very high, with most of the patients reporting a good visual quality at far, intermediate and near distances (Group 1). PCO incidence was 0% during the follow up and IOL centration was stable at 6 month after surgery in Group 1.

Conclusions:

The evaluated Alcon AcrySof® IQ PanOptix® provides a very good performance of the visual function after cataract surgery, with high levels of distance, intermediate and near visual acuity, good levels of contrast sensitivity, patient satisfaction, no PCO incidence and high stability of IOL centration.

Financial Disclosure:

None